Literature DB >> 15716236

Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.

Anjali Saqi1, Diane Alexis, Fabrizio Remotti, Govind Bhagat.   

Abstract

Carcinoids of different organs appear morphologically indistinguishable. We studied the usefulness of differential expression of CDX2 and thyroid transcription factor-1 (TTF-1) in 78 gastrointestinal and pulmonary carcinoids and their metastases (n = 10). CDX2 staining of gastric biopsy specimens with neuroendocrine hyperplasia (n = 11) and various gastritides (n = 10) was also performed. All ileal (6/6 [100%]), 6 (86%) of 7 appendiceal, 3 (75%) of 4 duodenal, 1 (50%) of 2 ampullary, 12 (33%) of 18 rectal, 6 (30%) of 20 pancreatic, and 1 (17%) of 6 gastric carcinoids expressed CDX2 with variable intensity; none of the pulmonary carcinoids stained. Of 15 pulmonary carcinoids, 8 (53%) stained with TTF-1, but none of the gastrointestinal carcinoids did. CDX2 and TTF-1 staining profiles of primary and metastatic carcinoids were similar. CDX2+ gastric endocrine cells had a distribution similar to that of gastrin and enterochromaffin cells but not enterochromaffin-like cells. Our results suggest that CDX2 and TTF-1 have high specificity for gastrointestinal and pulmonary carcinoids, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716236     DOI: 10.1309/UKN6-PVRK-XHG4-22DA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  26 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Pathological diagnosis and treatment outcome of gastric metastases from small cell lung cancer: A case report.

Authors:  Yanmei Peng; Qing Liu; Ye Wang; Aiping Song; Hua Duan; Yuqin Qiu; Qiang Li; Hui-Juan Cui
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

3.  Pathology for the HPB Surgeon.

Authors:  Chandralekha Tampi
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

Review 4.  Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Authors:  José Manuel Cameselle-Teijeiro; José Antonio Mato Mato; Ovidio Fernández Calvo; Jesús García Mata
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

5.  TTF-1 positive small cell cancers: Don't think they're always primary pulmonary!

Authors:  Laurine Verset; Marianna Arvanitakis; Patricia Loi; Jean Closset; Myriam Delhaye; Myriam Remmelink; Pieter Demetter
Journal:  World J Gastrointest Oncol       Date:  2011-10-15

Review 6.  Cutaneous metastases as an initial manifestation of visceral well-differentiated neuroendocrine tumor: a report of four cases and a review of literature.

Authors:  Jaroslaw Jedrych; Klaus Busam; David S Klimstra; Melissa Pulitzer
Journal:  J Cutan Pathol       Date:  2013-12-03       Impact factor: 1.587

7.  Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.

Authors:  Epameinondas Dogeas; Georgios Karagkounis; Christopher M Heaphy; Kenzo Hirose; Timothy M Pawlik; Christopher L Wolfgang; Alan Meeker; Ralph H Hruban; John L Cameron; Michael A Choti
Journal:  J Am Coll Surg       Date:  2014-01-10       Impact factor: 6.113

Review 8.  Nkx2-1: a novel tumor biomarker of lung cancer.

Authors:  Li Yang; Min Lin; Wen-jing Ruan; Liang-liang Dong; En-guo Chen; Xiao-hong Wu; Ke-jing Ying
Journal:  J Zhejiang Univ Sci B       Date:  2012-11       Impact factor: 3.066

9.  SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

Authors:  Zhongwu Li; Jing Yuan; Lixin Wei; Lixin Zhou; Kaiyong Mei; Junqiu Yue; Hongwen Gao; Miao Zhang; Ling Jia; Qiang Kang; Xiaozheng Huang; Dengfeng Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.

Authors:  Jamie Koo; Xiaoyan Zhou; Elizabeth Moschiano; Mariza De Peralta-Venturina; Richard B Mertens; Deepti Dhall
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.